Correlation of cyclosporine A blood concentration with kidney injury for pediatric patients after hematopoietic stem cell transplantation: a retrospective cohort study.

Background: The potential nephrotoxicity of cyclosporine A (CsA) has been a problem for treating graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the relationship between CsA blood concentration and acute kidney injury (AKI) in pediatric...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 81; no. 3; pp. 395 - 402
Autores principales: Shi, Wei, Qiu, Xin, Huang, Liang, Zeng, Linan, Lu, Runxin, Li, Hailong, Zou, Kun, Jia, Zhijun, Cheng, Guo, Yu, Qin, Zhao, Limei, Zhang, Lingli
Formato: research tables/charts Journal Article
Publicado: Springer Nature Mar2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183079871&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 183079871
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Mar2025
      vid: 81
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        183079871
        182090228
        183079871
        183079871
        10.1007/s00228-024-03792-5
        183079871
      ppf: 395
      ppct: 7
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Correlation of cyclosporine A blood concentration with kidney injury for pediatric patients after hematopoietic stem cell transplantation: a retrospective cohort study.
      aug:
        au:
          Shi, Wei
          Qiu, Xin
          Huang, Liang
          Zeng, Linan
          Lu, Runxin
          Li, Hailong
          Zou, Kun
          Jia, Zhijun
          Cheng, Guo
          Yu, Qin
          Zhao, Limei
          Zhang, Lingli
        affil: NMPA Key Laboratory for Technical Research On Drug Products In Vitro and In Vivo Correlation, 610041, Chengdu, China
      sug:
        subj:
          Hematopoietic Stem Cell Transplantation
          Allogeneic Cells
          Cyclosporine Adverse Effects
          Cyclosporine Blood
          Kidney Failure, Acute Risk Factors
          Risk Assessment
          Pediatric Care
          Human
          Funding Source
          Male
          Female
          Child, Preschool
          Child
          Retrospective Design
          Record Review
          Prospective Studies
          Graft Versus Host Disease
          Nephrotoxicity
          Child, Preschool: 2-5 years
          Child: 6-12 years
          Male
          Female
      ab: Background: The potential nephrotoxicity of cyclosporine A (CsA) has been a problem for treating graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the relationship between CsA blood concentration and acute kidney injury (AKI) in pediatric patients after allo-HSCT remains unclear. Methods: We performed a retrospective study including pediatric patients who received allo-HSCT in West China Second Hospital of Sichuan University from 2000 to 2022 and collected their clinical data. Included patients' CsA blood concentration were divided into three cohorts according to the guideline. Multivariate logistic regression was used to estimate the relationship between AKI and CsA blood concentration and other factors. And the maximum cut-off value for the safe blood concentration range of CsA was obtained by the receiver operating characteristic (ROC) curve. Results: Seventy-nine patients (average age 6.75 ± 4.25) were included. The incidence of kidney injury for three CsA blood concentration cohorts (< 200 ng/ml, 200–300 ng/ml, > 300 ng/ml) were 21.30%, 23.50%, and 66.70%, respectively. A multivariate logistic regression identified CsA blood concentration (> 300 ng/ml) and infection were risk factors for AKI (OR <200 ng/ml: 0.115, 95% CI: 0.029–0.458; OR 200–300 ng/ml: 0.184, 95% CI: 0.036–0.929; OR infection: 5.006, 95% CI: 1.491–16.810). Meanwhile, the maximum cut-off value for the safe blood concentration range of CsA is 276.85 ng/ml with an AUC value of 0.684 (P = 0.010). Conclusion: In conclusion, clinical treatment for the pediatric patients after allo-HSCT may be considered to control the blood concentration of CsA in 200–276.85 ng/ml and closely monitoring patients who have infections.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N